Evaluating Stryker: Insights From 9 Financial Analysts
Portfolio Pulse from Benzinga Insights
Nine financial analysts have recently provided ratings on Stryker (NYSE:SYK), with a mix of bullish and somewhat bullish perspectives dominating. The average 12-month price target for SYK has been raised to $361.11, indicating a 6.52% increase from the previous target of $339.00. Analysts from firms including Citigroup, RBC Capital, Truist Securities, Roth MKM, Canaccord Genuity, and Wells Fargo have adjusted their ratings and price targets, reflecting a positive outlook on Stryker's performance. Stryker's financial indicators such as market capitalization, revenue growth, net margin, ROE, and ROA are strong, although its debt-to-equity ratio suggests potential financial challenges.
April 03, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stryker has received positive ratings and an increased average 12-month price target from nine financial analysts, indicating a bullish outlook on the stock.
The increase in the average 12-month price target for Stryker, along with the predominantly bullish ratings from analysts, suggests a positive sentiment towards the company's stock. This is further supported by Stryker's strong financial performance indicators such as revenue growth, net margin, ROE, and ROA. However, the company's higher debt-to-equity ratio is a point of caution. Overall, the analyst consensus and financial health indicators point towards a likely short-term appreciation in SYK's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100